Rubius Therapeutics Reports First Quarter 2020 Financial Results and Provides Operational Update
Completed Strategic Reprioritization of Pipeline to Focus on Oncology and AutoimmunityDosed First Patient in Phase 1/2 Clinical Trial of RTX-240 […]
Pixelworks to Participate at Upcoming May Financial Conferences
SAN JOSE, Calif., May 11, 2020 (GLOBE NEWSWIRE) — Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and […]
TRHC and ASCP Sign Letter of Intent to offer MedWise™ to Consultant Pharmacists
MOORESTOWN, N.J., May 11, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare®, Inc. (TRHC) (Nasdaq: TRHC), a healthcare technology company advancing […]
TSX News -
Savaria Announces Two Contracts Totaling $3 Million Home Elevators to “Stay At Home With Savaria”
LAVAL, Québec, May 11, 2020 (GLOBE NEWSWIRE) — Savaria Corporation (“Savaria”) (TSX: SIS) one of the global leaders in the […]
CorePoint Lodging Announces Timing of First Quarter 2020 Earnings Release and Conference Call
IRVING, Texas, May 11, 2020 (GLOBE NEWSWIRE) — CorePoint Lodging Inc. (NYSE: CPLG) (“CorePoint” or the “Company”) today announced that […]
TSX News -
Trisura Group Ltd. Announces C$42.5 Million Bought Deal Public Offering and Concurrent Private Placement of C$7.5 Million
Not for distribution to U.S. news wire services or dissemination in the United States.TORONTO, May 11, 2020 (GLOBE NEWSWIRE) — […]
Altisource Asset Management Corporation Reports First Quarter 2020 Results
CHRISTIANSTED, U.S. Virgin Islands, May 11, 2020 (GLOBE NEWSWIRE) — Altisource Asset Management Corporation (“AAMC” or the “Company”) (NYSE American: […]
Front Yard Residential Corporation Reports First Quarter 2020 Results
CHRISTIANSTED, U.S. Virgin Islands, May 11, 2020 (GLOBE NEWSWIRE) — Front Yard Residential Corporation (“Front Yard” or the “Company”) (NYSE: […]
Wave Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
Data from both PRECISION-HD clinical trials expected in 2H 2020Advancing clinical neurology pipeline − SNP3 and C9orf72 programs on track […]
BridgeBio Pharma’s QED Therapeutics Announces Preclinical Data Demonstrating Potential of Low-Dose Infigratinib in Achondroplasia
SAN FRANCISCO, May 11, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) affiliate QED Therapeutics announced today that in […]
